Serologic and immunohistochemical prognostic biomarkers of cutaneous malignancies-Reference-Cited by-同舟云学术

Serologic and immunohistochemical prognostic biomarkers of cutaneous malignancies

Published:2007-01-13 Issue:10 Volume:298 Page:469-477
ISSN:0340-3696
Container-title:Archives of Dermatological Research
language:en
Short-container-title:Arch Dermatol Res

Author:

Utikal Jochen,Schadendorf Dirk,Ugurel Selma

Publisher

Springer Science and Business Media LLC

Subject

Dermatology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00403-006-0726-5.pdf

Reference94 articles.

1. Acland K, Evans AV, Abraha H, Healy CM, Roblin P, Calonje E, Orchard G, Higgins E, Sherwood R, Russell-Jones R (2002) Serum S100 concentrations are not useful in predicting micrometastatic disease in cutaneous malignant melanoma. Br J Dermatol 146:832–835

2. Agrup P, Carstam R, Wittbjer A, Rorsman H, Rosengren E (1989) Tyrosinase activity in serum from patients with malignant melanoma. Acta Derm Venereol 69:120–124

3. Alonso SR, Ortiz P, Pollan M, Perez-Gomez B, Sanchez L, Acuna MJ, Pajares R, Martinez-Tello FJ, Hortelano CM, Piris MA, et al (2004) Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study. Am J Pathol 164:193–203

4. Andersen K, Nesland JM, Holm R, Florenes VA, Fodstad O, Maelandsmo GM (2004) Expression of S100A4 combined with reduced E-cadherin expression predicts patient outcome in malignant melanoma. Mod Pathol 17:990–997

5. Bachmann IM, Straume O, Puntervoll HE, Kalvenes MB, Akslen LA (2005) Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma. Clin Cancer Res 11:8606–8614

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic LRG1 Expression in Melanoma is Associated with Disease Progression and Recurrence;Cancer Research Communications;2023-04-20

2. Significance of 5-S-Cysteinyldopa as a Marker for Melanoma;International Journal of Molecular Sciences;2020-01-09

3. Diagnosis of Stage IV Melanoma;Cutaneous Melanoma;2020

4. Eosinophil-cationic protein - a novel liquid prognostic biomarker in melanoma;BMC Cancer;2019-03-07

5. Diagnosis of Stage IV Melanoma;Cutaneous Melanoma;2019